Host Dr. Alan Brown continues his series of conversations demystifying familial hypercholesterolemia (FH), this week with Dr. Paul Hopkins, co-director of cardiovascular genetics and director of the Cardiovascular Disease Prevention Clinic at the University of Utah. They define FH from a genetics perspective, and discuss genetic causes, prevalence, populations with higher prevalence, and screening guidelines.
Diagnosis, Prevalence, and Screening of Familial Hypercholesterolemia

Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
Host Dr. Alan Brown continues his series of conversations demystifying familial hypercholesterolemia (FH), this week with Dr. Paul Hopkins, co-director of cardiovascular genetics and director of the Cardiovascular Disease Prevention Clinic at the University of Utah. They define FH from a genetics perspective, and discuss genetic causes, prevalence, populations with higher prevalence, and screening guidelines.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Innovations in the Management of Hemolytic Disease of the Fetus and Newborn: The Role of the Neonatal Fc Receptor (FcRn) Pathway
Advances in MASLD/MASH: Treating the Liver, the Disease, and the Patient – Chair’s Perspective
M3: Managing the Cardiometabolic Risk in MASH
HF Management for Patients with Comorbid Conditions
Level Up Your Skills: Tailoring Management of HF
Clinical Conundrums in ARIA: 1. Navigating the Baseline MRI for Anti-Aβ Monoclonal Antibodies
Impact of Barostim on Heart Failure Hospitalization
Navigating Myasthenia Gravis in Adolescents and Young Adults
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?